Figure 3From: SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer? Overall survival of combined patient population receiving adjuvant tamoxifen or chemotherapy according to the SULT1A1 rs9282861 genotype. The black solid line represents patients homozygous or heterozygous for the rs9282861 G allele and the black dotted line represents patients homozygous for the rs9282861 A allele. Adjustments were made for stage, age, radiation therapy, and hormone receptor status.Back to article page